Prostate Cancer - Results from #20

Survival of Men with Metastatic Hormone-Sensitive Prostate Cancer and Adrenal-Permissive HSD3B1 Inheritance - Beyond the Abstract October 15, 2024

Multiplex Imaging of Localized Prostate Tumors Reveals Altered Spatial Organization of AR-Positive Cells in the Microenvironment - Beyond the Abstract October 9, 2024

The Man Van: A Pilot Study of Using Mobile Targeted Case-Finding to Address Health Inequalities in Prostate Cancer - Beyond the Abstract October 8, 2024

Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial - Beyond the Abstract October 8, 2024

Impact of a Rash Management Guide in Patients Receiving Apalutamide for High-Risk Localized Prostate Cancer in the Apa-RP Study - Beyond the Abstract October 7, 2024

Hospital-Level Variability in the Adoption of Image-Guided Focal Therapy for Localized Prostate and Kidney Cancer - Beyond the Abstract October 3, 2024

Prospective Comparison of 68Ga-NeoB and 68Ga-PSMA-R2 PET/MRI in Patients with Biochemically Recurrent Prostate Cancer - Beyond the Abstract September 26, 2024

Identifying Barriers to Timely Follow-up After Elevated PSA Screening: A Retrospective Analysis of a Large Healthcare System - Beyond the Abstract September 25, 2024

Cost-Utility Analysis of Navigate, a Treatment Decision Aid for Men with Prostate Cancer and Their Partners, in Comparison to Usual Care - Beyond the Abstract September 25, 2024

Neurologic Symptoms after 177Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience - Beyond the Abstract September 25, 2024

5-α Reductase Inhibitors and Prostate Cancer Mortality - Beyond the Abstract September 20, 2024

Racial, Ethnic, and Socioeconomic Disparities in Rates of Stage IV Prostate Cancer After USPSTF Category "D" Recommendation Against Prostate-Specific Antigen Screening: A Retrospective Cohort Study - Beyond the Abstract September 11, 2024

Long Noncoding RNA EPCART Regulates Translation Through PI3K/AKT/mTOR Pathway and PDCD4 in Prostate Cancer - Beyond the Abstract September 9, 2024

Combination of PARP Inhibitors and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer - Beyond the Abstract September 4, 2024

Impact of Time to Metastatic Disease Onset and Extent of Disease Volume Across Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer - Beyond the Abstract September 3, 2024

Combining PSMA-PET and PROMISE to Re-Define Disease Stage and Risk in Patients with Prostate Cancer: A Multicentre Retrospective Study - Beyond the Abstract September 3, 2024

De-Escalation of Monitoring in Active Surveillance for Prostate Cancer: Results from the GAP3 Consortium - Beyond the Abstract August 30, 2024

Prostate Cancers with Distinct Transcriptional Programs in Black and White Men - Beyond the Abstract August 27, 2024

Recovery of Social Continence and Sexual Function in Men With High-risk Prostate Cancer after Radical Prostatectomy: Results From a Statewide Collaborative - Beyond the Abstract August 19, 2024

Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study - Beyond the Abstract August 1, 2024

Page 2 of 58